GapMinder, a venture capital firm investing in technology startups from Romania and Eastern Europe, is leading a €10 million seed funding round in Croatian healthtech startup Lasken AI. The funding will support the expansion of Lasken AI's proprietary healthcare data platform and its commercial growth across Europe.
TL;DR
- GapMinder leads a €10 million seed round in Lasken AI to expand its healthcare data intelligence platform.
- Lasken AI transforms publicly available healthcare information into structured datasets for pharmaceutical companies and healthcare organizations.
- The investment will support the expansion of Lasken AI's platform across Europe, starting with Germany.
What happened
GapMinder is leading a €10 million seed funding round in Lasken AI, alongside Fil Rouge Capital. The funding will support the expansion of Lasken AI's proprietary healthcare data platform, further product development, and commercial growth across Europe.
Lasken AI connects 400,000 healthcare organizations in Germany, millions of healthcare professionals, and more than half a trillion words from publicly available healthcare sources. By the end of 2026, this foundation is expected to expand to approximately 2.5 million healthcare organizations across Europe.
The investment adds to GapMinder's growing portfolio of technology and AI-driven companies, including InsiderCX, Codeplain, Design Verse, SalesTools, VoicePatrol, and Etiq AI.
Why it matters
Lasken AI's platform provides a continuously updated, structured dataset for pharmaceutical companies and healthcare organizations, enabling them to make informed commercial decisions.
The investment will support the development of new capabilities in semantic understanding, organizational and market intelligence, persona building, and advanced commercial analytics.
Lasken AI's goal is to help healthcare organizations better understand markets, professionals, and opportunities, enabling smarter commercial decisions through a single trusted data foundation.
Key facts
- GapMinder is leading a €10 million seed funding round in Lasken AI.
- Lasken AI connects 400,000 healthcare organizations in Germany and plans to expand to 2.5 million across Europe by the end of 2026.
- Lasken AI's customers include pharmaceutical and healthcare companies, healthtech firms, contract sales organizations, consultancies, and other service providers.
- The investment will support the expansion of Lasken AI's platform across Europe, starting with Germany.
- Lasken AI was founded by Patric Jarchow and Leonard Unger, who combine decades of healthcare expertise with extensive experience in building modern technology products.
- GapMinder's investment will support Lasken AI's rollout in Germany, establishing a strong foundation for further growth in the coming years.
- The funding will also support the development of new capabilities in semantic understanding, organizational and market intelligence, persona building, and advanced commercial analytics.
Context
Lasken AI's platform tracks how healthcare organizations, professionals, and markets evolve over time, making changes visible and measurable.
Unlike traditional datasets that provide static snapshots of markets, Lasken AI creates a living history of healthcare ecosystems.
The platform transforms this foundation into actionable intelligence, providing customers with ready-to-use insights, including target groups, market segments, site selections, and commercial recommendations.